Hepatitis B and C virus serologies among Japanese Americans with hepatocellular carcinoma

Journal of Infectious Diseases

Volumn 173, Issue 6, 1996, Pages 1474-1476

  Nomura, Abraham ^a   Stemmermann, Grant N ^c   Chyou, Po Huang ^c   Tabor, Edward ^b  

^a KUAKINI MEDICAL CENTER   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTIBODY DETECTION; ANTIGEN DETECTION; ARTICLE; CANCER DIAGNOSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SERODIAGNOSIS; UNITED STATES; VIRUS DETECTION;

EID: 0029838229     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/173.6.1474     Document Type: Article

References (14)

1. Acadia K. Hepatitis C virus and hepatocellular carcinoma. In: Tabor E, Di Bisceglie AM, Purcell RH, eds. Etiology, pathology, and treatment of hepatocellular carcinoma in North America. Woodlands, TX: Portfolio Publishing, 1991:119-26.
2. Kiyosawa K, Furuta S. Clinical aspects and epidemiology of hepatitis B and C viruses in hepatocellular carcinoma in Japan. Cancer Chemother Pharmacol 1992;31:S150-6.
3. Bruix J, Barrera JM, Calvert X, et al. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 1989;2:1004-6.
4. Colombo M, Kuo G, Choo QL, et al. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet 1989; 2:1006-8.
5. Yu MC, Tong MJ, Coursaget P, Ross RK, Govindarajan S, Henderson BE. Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States. J Natl Cancer Inst 1990;82:1038-41.
6. Kew MC, Houghton M, Choo QL, Kuo G. Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinoma. Lancet 1990; 335:873-4.
7. Kaklamani E, Trichopoulos D, Tzonou A, et al. Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma. JAMA 1991;265:1974-6.
8. Doll R, Muir CS, Waterhouse JAH, eds. Cancer incidence in five continents. Vol II. Geneva: Union Internationale Contre le Cancer, 1970.
9. Waterhouse J, Muir C, Correa P, Powell J, eds. Cancer incidence in five continents. Vol III. Lyon, France: International Agency for Research on Cancer, 1976; scientific publication no. 15.
10. Waterhouse J, Muir C, Shanmugaratham K, Powell J, eds. Cancer incidence in five continents. Vol IV. Lyon, France: International Agency for Research on Cancer, 1982; scientific publication no. 42.
11. Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J, Powell J, eds. Cancer incidence in five continents. Vol VI. Lyon, France: International Agency for Research on Cancer, 1992; scientific publication no. 120.
12. Worth RM, Kagan A. Ascertainment of men of Japanese ancestry in Hawaii through World War II Selective Service registration. J Chron Dis 1970;23:389-97.
13. Breslow NE, Day NE. Statistical methods in cancer research. Vol 1. The analysis of case-control studies. Lyon, France: International Agency for Research on Cancer, 1980:164-6, 247-7; scientific publication no. 32.
14. Tanaka H, Hiyama T, Tsukuma H, et al. Prevalence of second generation antibody to hepatitis C virus among voluntary blood donors in Osaka, Japan. Cancer Causes Control 1994;5:409-I3.